She has been a practicing medical oncologist with a speciality in gastrointestinal cancer for 12 years and has enrolled over 100 patients on clinical trials. Her clinical interests include biomarkers in gastrointestinal cancers and new drug development trials. Dr. Goodwin is an active member of the Canadian Cancer Trials Group where she is New Drug Development Liaison and co-chair for the Colon Cancer Disease Site Group.